Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,280.80
(
-0.66%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
99.09
(
-0.76%
)
Bitcoin
70,751.99
(
-0.03%
)
News Focus
News Focus
Post# of 821158
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 24
Posts 4168
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: survivor1x post# 545635

Thursday, 12/08/2022 1:43:06 AM

Thursday, December 08, 2022 1:43:06 AM

Post# of 821158
This trial doesn't tell you that -- there are few participants that only received a single dose. Can tell.

The issue is the validity of the trial. It has significant deficiencies that make reading the results difficult -- confounding, statistical manipulations, small recurrent OS sample. Regulators will find it difficult to read results.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News